- Medicinal Marijuana, along with several other drugs awaiting clinical trail results, in addition to FDA approval, will now be legally available to the terminally ill.
- “Right to Try Bill was passed unanimously by the Senate last summer and by the House of Representatives on Tuesday [ May 22] in a vote of 250 to 169.”
- Trump: ” People who are terminally ill should not have to go from country to country to seek a cure. I want to give them a chance right here at home.”
The ‘Right To Try’ bill will legalize medications considered life-saving that have yet to go through the entire FDA-approval process.
President Trump is set to sign legislation which could make medical marijuana federally legal for terminally ill patients. The bill, known as the “Right to Try Act,” would allow patients with potentially fatal conditions to try medications that have not yet been approved by the FDA, but are undergoing the approval process and have already passed the first phase of clinical studies.
Right to Try was passed unanimously by the Senate last summer and by the House of Representatives on Tuesday in a vote of 250 to 169.
While the bill’s provisions are targeted at a wide range of medications, it appears they might also apply to medical cannabis thanks to a clinical trial being conducted by the Multidisciplinary Association of Psychedelic Sciences (MAPS).
The MAPS trial, currently in the second phase of the FDA approval process, is testing the effectiveness of smoked cannabis in veterans with PTSD and meets all of the criteria set out by the Right to Try.
The majority of states already have their own form of Right to Try legislation, with one notable exception being New York. In Utah, a recently passed law specifically addresses the right of terminally ill patients to try cannabis. However, because cannabis remains federally prohibited, even if a terminally ill patient has the “Right to Try” cannabis on the state level, they’re still in violation of federal law. The Right to Try